HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Resetting the detection level of cord blood thyroid stimulating hormone (TSH) for the diagnosis of congenital hypothyroidism.

AbstractAn appraisal of a 17-year primary thyroid stimulating hormone (TSH) screening programme for the detection of congenital hypothyroidism was carried out to establish the reference interval of cord blood TSH in unaffected infants; the mean cord blood TSH concentration of affected infants and the incidence of congenital hypothyroidism in the Najran province of Saudi Arabia. Our findings show a reference interval of cord blood TSH of 2.0-16.8 mU/l in unaffected infants; a mean cord blood TSH concentration of 399 mU/l in affected infants; a false positive rate for the diagnosis of at-risk infants of 1.02% and a congenital hypothyroidism incidence rate of 34/100 000 (1 : 2931) live births. These findings suggest that there is a need to reset the cord blood TSH concentration for the detection of at-risk infants. We suggest that the detection level of cord blood TSH for the recognition of at-risk infants can be set at 90 mU/l rather than the recommended level of 30 mU/l. This should reduce the false positive rate for detection of infants at risk of congenital hypothyroidism.
AuthorsO O Ogunkeye, A I Roluga, F A Khan (Affiliation: Laboratory Departments, King Khalid Hospital, Najran, Kingdom of Saudi Arabia. obaogunkeye at hotmail.com)
JournalJournal of tropical pediatrics (J Trop Pediatr) Vol. 54 Issue 1 Pg. 74-7 (Feb 2008) ISSN: 0142-6338 [Print] England
PMID17878179 (Publication Type: Journal Article, Multicenter Study)
Chemical References
  • Thyrotropin
Topics
  • Congenital Hypothyroidism (blood, diagnosis, epidemiology)
  • False Positive Reactions
  • Fetal Blood (chemistry)
  • Humans
  • Incidence
  • Infant, Newborn
  • Neonatal Screening (methods)
  • ROC Curve
  • Reference Values
  • Saudi Arabia (epidemiology)
  • Thyrotropin (blood, diagnostic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $45.00 USD